News
Active Startup: Corbin Therapeutics Inc.
Published: 10 October 2019
Business Snapshot
Using a unique drug discovery platform to identify and develop novel inhibitors for treatment of various inflammation diseases, such as multiple sclerosis. This platform includes several in-vitro and in-vivo models for efficient drug screening and confirmation of potential lead candidates.
Target Markets
Inflammation (neuro-inflammation in particular)
Intellectual Property
Granted in Europe, in prosecution elsewhere.
Founder
Philippe Gros